Abstract
Of three enzymes encoded by HIV–reverse transcriptase, protease, and integrase—only the first two have been exploited clinically as inhibitor targets. Efforts to develop inhibitors of purified integrase protein have yielded many compounds, but none with clinical utility. A different source of integration activity for studies in vitro is provided by replication intermediates isolated from HIV-infected cells. These preintegration complexes (PICs) can direct integration of the endogenously synthesized viral cDNA into an added target DNA in vitro. Despite their authentic activities, assays of PICs have not been widely used due to technical obstacles, particularly the requirement for handling large amounts of infectious HIV. Here, we describe greatly improved methods for producing PICs using HIV-based vectors that are capable of establishing an integrated provirus but not a spreading infection. We also report the development of a PIC integration assay using DNA-coated microtiter plates, which speeds assays of PIC integration in vitro. We used this method to screen a library of chemicals related to known integrase inhibitors and found a new compound, quinalizarin sulfate, that displayed enhanced activity against PICs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Coffin, J.M., Hughes, S.H. & Varmus, H.E. Retroviruses (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1997).
Bushman, F.D., Landau, N.R. & Emini, E.A. New developments in the biology and treatment of HIV. Proc. Natl. Acad. Sci. USA 95, 11041– 11042 (1998).
Pommier, Y., Pilon, A.A., Bajaj, K., Mazumder, A. & Neamati, N. HIV-1 integrase as a target for antiviral drugs. Antivir. Chem. Chemother. 8, 463–483 (1997).
Hansen, M.S.T., Carteau, S., Hoffmann, C., Li, L. & Bushman, F. in Genetic engineering. Principles and methods (ed. Setlow, J.K.) 41–62 (Plenum, New York and London, 1998).
Patel, P.H. & Preston, B.D. Marked infidelity of human immunodeficiency virus type 1 reverse transcriptase at RNA and DNA template ends. Proc. Natl. Acad. Sci. USA 91, 549– 553 (1994).
Miller, M.D., Farnet, C.M. & Bushman, F.D. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71, 5382–5390 (1997).
Brown, P.O., Bowerman, B., Varmus, H.E. & Bishop, J.M. Correct integration of retroviral DNA in vitro. Cell 49, 347–356 (1987).
Farnet, C.M. & Haseltine, W.A. Integration of human immunodeficiency virus type 1 DNA in vitro. Proc. Natl. Acad. Sci. USA 87, 4164–4168 (1990).
Ellison, V.H., Abrams, H., Roe, T., Lifson, J. & Brown, P.O. Human immunodeficiency virus integration in a cell-free system. J. Virol. 64, 2711– 2715 (1990).
Hansen, M. & Bushman, F.D. HIV-2 preintegration complexes: activities in vitro and response to inhibitors. J. Virol. 71, 3351–3356 (1997).
Lee, Y.M.H. & Coffin, J.M. Relationship of avian retrovirus DNA synthesis to integration in vitro. Mol. Cell Biol. 11, 1419–1430 (1991).
Bukrinsky, M.I. et al. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. USA 90, 6125–6129 (1993).
Gallay, P., Swingler, S., Song, J., Bushman, F. & Trono, D. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 17, 569–576 (1995).
Farnet, C.M. & Haseltine, W.A. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J. Virol. 65, 1910–1915 (1991).
Farnet, C. & Bushman, F.D. HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro. Cell 88, 1–20 ( 1997).
Wei, S.-Q., Mizuuchi, K. & Craigie, R. Footprints of the viral DNA ends in Moloney murine leukemia virus preintegration complexes reflect a specific association with integrase. Proc. Natl. Acad. Sci. USA 95, 10535– 10540 (1998).
Lee, Y.M.H. & Coffin, J.M. Efficient autointegration of avian retrovirus DNA in vitro. J. Virol. 64, 5958 –5965 (1990).
Bushman, F.D., Fujiwara, T. & Craigie, R. Retroviral DNA integration directed by HIV integration protein in vitro. Science 249, 1555– 1558 (1990).
Bushman, F.D. & Craigie, R. Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proc. Natl. Acad. Sci. USA 88, 1339–1343 (1991).
Hazuda, D.J., Felock, P.J., Hastings, J.C., Pramanik, B. & Wolfe, A.L. Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase. J. Virol. 71, 7005– 7011 (1997).
Hindmarsh, P. et al. HMG protein family members stimulate human immunodeficiency virus type 1 avain sarcoma virus concerted DNA integration in vitro. J. Virol. 73, 2994–3003 (1999).
Farnet, C., Lipford, R., Wang, B. & Bushman, F.D. Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules. Proc. Natl. Acad. Sci. USA 93, 9742–9747 (1996).
Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263 –267 (1996).
Kafri, T., van Praag, H., Ouyang, L., Gage, F.H. & Verma, I.M. A packaging cell line for lentiviral vectors. J. Virol. 73, 573– 584 (1999).
Gossen, M. et al. Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766–1769 ( 1995).
Gibson, U., Heid, C.A. & Williams, P.M. A novel method for real time quantitative RT PCR. Genome Res. 6, 995–1001 (1996).
Heid, C.A., Stevens, J., Livak, K.J. & Williams, P.M. Real time quantitative PCR. Genome Res. 6, 986– 994 (1996).
Cushman, M. & Sherman, P. Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions. Biochem. Biophys. Res. Commun. 185, 85–90 (1992).
Robinson, W.E., Reinecke, M.G., Abdel-Malek, S., Jia, Q. & Chow, S.A. Inhibitors of HIV-1 replication that inhibit HIV integrase. Proc. Natl. Acad. Sci. USA 93 , 6326–6331 (1996).
Farnet, C.M. et al. Human immunodeficiency virus type 1 integration: new aromatic hydroxylated inhibitors and studies of the inhibition mechanism. Antimicrob. Agents Chemother. 42, 2245–2253 (1998).
Bartz, S.R. & Vodicka, M.A. Production of high-titer human immunodeficiency virus yype 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods 12, 337– 342 (1997).
King, P.J. & Robinson, W.E.J. Resistance to the anti-human immunodeficiency virus type 1 compound L-chicoric acid results from a single mutation at amino acid residue 140 of integrase. J. Virol. 72, 8420–8424 (1998).
Miller, M.D., Wang, B. & Bushman, F.D. HIV-1 preintegration complexes containing discontinuous plus strands are competent to integrate in vitro. J. Virol. 69, 3938–3944 (1995).
Ghosh, S.S. & Musso, G.F. Covalent attachment of oligonucleotides to solid supports. Nucleic Acids Res. 15, 5353–5372 (1987).
Lund, V., Schmid, R., Rickwood, D. & Hornes, E. Assessment of methods for covalent binding of nucleic acids to magnetic beads, dynabeads, and the characteristics of the bound nucleic acids in hybridization reactions. Nucleic Acids Res. 16, 10861–10879 (1988).
Rasmussen, S.R., Larsen, M.R. & Rasmussen, S.E. Covalent immobilization of DNA onto polystyrene microwells: the molecules are only bound at the 5´ end. Anal. Biochem . 198, 138–142 ( 1991).
Chu, B.C.F., Wahl, G.M. & Orgel, L.E. Derivitization of unprotected polynucleotides. Nucleic Acids Res. 11, 6513–6529 (1983).
Hazuda, D.J., Hastings, J.C., Wolfe, A.L. & Emini, E.A. A novel assay for the DNA strand-transfer reaction of HIV-1 integrase. Nucleic Acids Res. 22, 1121–1122 (1994).
Acknowledgements
We thank members of the Bushman lab, Barbara Chu, Leslie Orgel, Matthew Helf, Francois Ferre, and Inder Verma for help and discussions and Alison Bocksruker for assistance with the manuscript. F.D.B. is a Scholar of the Leukemia Society of America. This work was supported by grants GM56553 and AI34786 to F.D.B.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hansen, M., Smith, G., Kafri, T. et al. Integration complexes derived from HIV vectors for rapid assays in vitro . Nat Biotechnol 17, 578–582 (1999). https://doi.org/10.1038/9886
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/9886
This article is cited by
-
Mechanism of Reduction in Titers From Lentivirus Vectors Carrying Large Inserts in the 3′LTR
Molecular Therapy (2009)
-
Current status of targets and assays for anti-HIV drug screening
Virologica Sinica (2007)
-
Gene delivery by lentivirus vectors
Molecular Biotechnology (2007)
-
Integrase inhibitors to treat HIV/Aids
Nature Reviews Drug Discovery (2005)
-
A Three-dimensional Model of the Human Immunodeficiency Virus Type 1 Integration Complex
Journal of Computer-Aided Molecular Design (2005)